Author:
Stine Jonathan G.,Intagliata Nicolas,Shah Neeral L.,Argo Curtis K.,Caldwell Stephen H.,Lewis James H.,Northup Patrick G.
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,Physiology
Reference29 articles.
1. Lawitz E, Mangia A, Wyles D, et al. Sofosbuvir for previously untreated chronic hepatitis C infection. N Engl J Med. 2013;368:1878–1887.
2. Fried MW, Buti M, Dore GJ, et al. Once-daily simeprevir (TMC435) with pegylated interferon and ribavirin in treatment-naive genotype 1 hepatitis C: the randomized PILLAR study. Hepatology. 2013;58:1918–1929.
3. Zeuzem S, Berg T, Gane E, et al. Simeprevir increases rate of sustained virologic response among treatment-experienced patients with HCV genotype-1 infection: a phase IIb trial. Gastroenterology. 2014;146:430.e436–441.e436.
4. Gilead. In: Sofosbuvir Drug Package Insert. http://www.olysio.com/shared/product/olysio/prescribing-information.pdf . Accessed May 29, 2014.
5. FDA. Simeprevir Hearing. http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AntiviralDrugsAdvisoryCommittee/UCM375113.pdf ; 2013. Accessed June 20, 2014.
Cited by
59 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献